29th February 2020
  • 9:11 pm Through the Eyes of Ides Ofune – Women Shouldn’t Have to Choose Between Motherhood and Higher Education
  • 10:24 am Job Opportunity – Science Adviser
  • 4:56 pm Mosquito sterilization offers new opportunity to control diseases
  • 4:24 pm Togo partners with Dangote cement to transform phosphate into fertiliser
  • 3:25 pm Follow the Money wins Council of Europe Democracy Award
  • 3:17 pm Can we really afford not to be interested in Politics? Watch how to encourage politics in the family
Abasi 54gene

Do you still belong to those set of Africans who don’t believe in the continent and it’s people? This news should clear all disbelief! Nigeria’s Dr. Abasi Ene-Obong with his new company 54gene has raised US$4.5million to collect Africans’ DNA for 1st Pan-African biobank. This will help find genetically-based medicines to treat, for example, sickle cell diseases.

Taking to his website, he announced the good news ” Today, we are thrilled to welcome the new investors and partners who are joining us in pursuit of this big vision: Y Combinator, Fifty Years, Better Ventures, KdT Ventures, Hack VC, and Techammer, among others, will be joining the 54gene family. The $4.5M seed round, announced this afternoon by TechCrunch, will enable us to continue building our pan-African biobank as we expand across the continent and partner with research and development organizations around the world.”

54gene has set out to unlock the African genome by building the world’s first and largest pan-African biobank. It says, “since African genomes have not been well represented in studies, there’s a chance that many of the new personalized medicines or diagnostics will not work well when administered to people of African origin. In addition, studying the African genome has the potential to uncover variations that will lead to new drug discoveries and benefit to people of all races.”

Congratulations to Dr. Abasi Ene-Obong and 54gene!